Support is not treatment: A shared language for the supplement conversation

Clients may arrive at appointments with a supplement already in hand to ask whether it works or is safe. A useful answer starts with the exact product, intended use, and evidence for that use. Animal supplements vary in quality and support for their claims, so neither a reassuring label nor a skeptical reflex can replace a clinical conversation.^1,2

The regulatory backdrop, in plain terms

In the US, the Dietary Supplement Health and Education Act created a distinct framework for human dietary supplements, but it does not apply to products for animals. FDA instead evaluates an animal product under its food or drug authorities, considering its ingredients and intended use. A claim to diagnose, cure, mitigate, treat, or prevent disease can make a product an animal drug. Even a claim about normal structure or function can raise a drug question if the effect is not derived mainly from the product's nutrition, taste, or aroma. In other words, "support" is not a regulatory safe word.^3,4

Why the words matter clinically

A label can frame a goal, but it does not establish that a particular product achieves it in a particular patient. Evidence differs by ingredient, dose, species, and formulation.1 The National Animal Supplement Council Quality Seal indicates that the company has passed a quality audit and meets program requirements for matters such as labeling and adverse-event reporting. It is a quality signal, not proof that a product is effective for a patient's condition.⁵
If a client hears "supports kidney health" as a substitute for evaluating kidney disease, the misunderstanding matters. The veterinary team can separate the client's goal from the product's actual evidence and keep the patient's diagnosis and prescribed care in view. Asking about supplements as part of the diet and medication history also helps surface potential adverse effects or interactions.^1,2

Questions to bring into the visit

A practice could give clients a short set of prompts:

• What is the specific goal for this product, and what condition, if any, is being treated separately?
• What evidence supports its use in this species and at this dose?
• What are the ingredients and amounts per serving?
• Could it affect this pet's medications, diet, or existing condition?

The practice can ask where the client obtained the product, request the full label, and ask when it was started and whether anything changed afterward. Recording the product and dose in the medical record keeps it within the clinical picture.^1,2

The takeaway

The best supplement discussion neither dismisses the client's interest nor treats a marketing claim as a clinical answer. It names the goal, checks the evidence and the full product, and plans to revisit the decision. Clear language helps everyone distinguish a product's proposed support from the treatment the patient may need.

Mark Garrison is the CEO of Bio Health Solutions, a manufacturer of animal nutritional products.

References

1. Finno CJ. Veterinary pet supplements and nutraceuticals. Nutr Today. 2020;55(2):97-101. doi:10.1097/NT.0000000000000399
2. Assessing pet supplements. JAVMA News. January 4, 2017. Accessed October 8, 2026. https://www.avma.org/javma-news/2017-01-15/assessing-pet-supplements
3. FDA's regulation of pet food. US Food and Drug Administration. Updated February 17, 2022. Accessed October 8, 2026. https://www.fda.gov/animal-veterinary/animal-health-literacy/fdas-regulation-pet-food
4. Animal food labeling and pet food claims. US Food and Drug Administration. Updated March 2, 2026. Accessed October 8, 2026. https://www.fda.gov/animal-veterinary/animal-foods-feeds/animal-food-labeling-and-pet-food-claims
5. NASC Quality Seal. National Animal Supplement Council. Accessed October 8, 2026. https://www.nasc.cc/nasc-seal/Finno CJ. Veterinary pet supplements and nutraceuticals. Nutr Today. 2020;55(2):97-101. doi:10.1097/nt.0000000000000399